Impact of Bebtelovimab Treatment Timing on COVID‐19 Outcomes in Ambulatory Solid Organ Transplant Recipients
Sonsoles Salto‐Alejandre(Instituto de Biomedicina de Sevilla), Robin K. Avery(Johns Hopkins University), Lauren Boyer(University of Baltimore), Mary G. Bowring(Johns Hopkins University), Daniel C. Brennan(Johns Hopkins University), William A. Werbel(Johns Hopkins University), Julie Langlee(Johns Hopkins Hospital), Willa Cochran(Johns Hopkins Hospital), Zishan K. Siddiqui(Johns Hopkins University), Ishaan Gupta(Johns Hopkins University), Kristin Freed(Johns Hopkins Hospital), Sophia Purekal(Johns Hopkins University)
Cited by 0
Related Papers
Foot strike patterns and collision forces in habitually barefoot versus shod runners
|Nature|2010|1.4k
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
|JAMA|2021|1k
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients
|JAMA|2021|536
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series
|Annals of Internal Medicine|2021|359
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial
|Clinical Infectious Diseases|2021|299